Neoadjuvant immunotherapy in patients with early-stage, high-risk, ER+/HER2-breast cancer: Physician practices, therapy choice, and barriers among us oncologists Meeting Abstract
| Authors: | Aggarwal, P.; Van Doren, B.; Jeune-Smith, Y.; Jennings-Zhang, L.; Bone, R. N.; Sadeghi, S.; Iyengar, N. M.; Feinberg, B. |
| Abstract Title: | Neoadjuvant immunotherapy in patients with early-stage, high-risk, ER+/HER2-breast cancer: Physician practices, therapy choice, and barriers among us oncologists |
| Meeting Title: | ISPOR Europe 2024 |
| Journal Title: | Value in Health |
| Volume: | 27 |
| Issue: | 12 Suppl. |
| Meeting Dates: | 2024 Nov 17-20 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 1098-3015 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2024-12-01 |
| Start Page: | S335 |
| Language: | English |
| ACCESSION: | WOS:001426382000093 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jval.2024.10.1732 |
| Notes: | Meeting Abstract: HSD49 -- Source: Wos |
